- Curriculum Vitae
- Office hour
- Third mission
1995: degree in Medicinal Chemistry and Pharmaceutical Technology, University of Parma (Italy).
1999: Ph.D. degree in Medicinal Chemistry and Pharmaceutical Technology, University of Pavia (Italy).
1998-2005: assistant professor of Medicinal Chemistry, University of Parma.
2005-2018: associate professor of Medicinal Chemistry, Department of Food and Drug, University of Parma.
2018-: full professor of Medicinal Chemistry, Department of Food and Drug, University of Parma.
2013-2018: member of the Scientific Committee for Chemical Sciences Area, University of Parma.
2014-2015: Director of the Library of the Faculty of Pharmacy.
2017-: Delegate of the Director of the Department of Food and Drug for teaching activities.
2018 -: visiting professor of the University of Lincoln (UK), School of Pharmacy.
Member of the Teachers Board of the Ph.D in Drugs, Biomolecules and Health Products, University of Parma.
Editorial board member for Journal of Pineal Research, Current Pharmaceutical Design, PeerJ.
Teaching activity of medicinal chemistry courses for the Degree in Pharmacy and for the School of Hospital Pharmacy, University of Parma.
Teaching activity for the Master in Drug Design and Development, University of Pavia.
Every day, by previous appointment.
Completion accademic year: 2019/2020
Completion accademic year: 2018/2019
Completion accademic year: 2017/2018
Completion accademic year: 2016/2017
- Course year: 3 - Full cicle (5 years) - PHARMACY - A.Y.: 2014/2015
- Full cicle (5 years) PHARMACY A.Y. 2020/2021
- DRUG SCIENCES A.Y. 2019/2020
- Full cicle (5 years) PHARMACY A.Y. 2019/2020
- Full cicle (5 years) PHARMACY A.Y. 2018/2019
- Full cicle (5 years) PHARMACY A.Y. 2017/2018
- Full cicle (5 years) PHARMACY A.Y. 2016/2017
- Full cicle (5 years) PHARMACY A.Y. 2015/2016
- Full cicle (5 years) PHARMACY A.Y. 2014/2015
University of Lincoln (UK), School of Pharmacy, 2018-2021.
Lines of research
Balancing reactivity and antitumor activity: heteroarylthioacetamide derivatives as potent and time-dependent inhibitors of EGFRYear: 2019Author/s: Castelli R, Bozza N, Cavazzoni A, Bonelli M, Vacondio F, Ferlenghi F, Callegari D, Silva C, Rivara S, Lodola A, Digiacomo G, Fumarola C, Alfieri R, Petronini PG, Mor M.
New Antimicrobials Targeting Bacterial RNA Polymerase Holoenzyme Assembly Identified with an in Vivo BRET-Based Discovery PlatformYear: 2019Author/s: Sartini S., Levati E., Maccesi M., Guerra M., Spadoni G., Bach S., Benincasa M., Scocchi M., Ottonello S., Rivara S., Montanini B.
Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in ratsYear: 2019Author/s: Vozella V., Ahmed F., Choobchian P., Merrill C. B., Zibardi C., Tarzia G., Mor M., Duranti A., Tontini A., Rivara S., Piomelli D.
Year: 2018Author/s: Rivara, Silvia, Scalvini, Laura, Lodola, Alessio, Mor, Marco, Caignard, Daniel-Henri, Delagrange, Philippe, Collina, Simona, Lucini, Valeria, Scaglione, Francesco, Furiassi, Lucia, Mari, Michele, Lucarini, Simone, Bedini, Annalida, Spadoni, Gilberto
Year: 2018Author/s: Madia, Valentina Noemi, Messore, Antonella, Pescatori, Luca, Saccoliti, Francesco, Tudino, Valeria, De Leo, Alessandro, Bortolami, Martina, Scipione, Luigi, Costi, Roberta, Rivara, Silvia, Scalvini, Laura, Mor, Marco, Ferrara, Fabiana Fosca, Pavoni, Emiliano, Roscilli, Giuseppe, Cassinelli, Giuliana, Milazzo, Ferdinando M., Battistuzzi, Gianfranco, Di Santo, Roberto, Giannini, Giuseppe
Spadoni G., Bedini A., Tarzia G., Mor M., Rivara S., Plazzi P.V., Fraschini F. Alchilammidi tricicliche: ligandi selettivi dei recettori melatoninergici MT1 e MT2. Italian patent N. 0001348600 granted on November 4th, 2008.
Gobbi G., Mor M., Rivara S., Fraschini F., Tarzia G., Bedini A., Spadoni G., Lucini V. Novel melatonin ligands having antidepressant activity as well as sleep inducing properties. US patent: US 8,791,163 granted on July 29, 2014; European patent: EP1973868(B1) granted on September 9, 2015.
Parco Area delle Scienze, 27/A